| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Almirall S.A (OTCGREY: LBTSF)
LBTSF Technical Analysis
5
| As on 10th Feb 2025 LBTSF STOCK Price closed @ 9.01 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 9.52 & Strong Sell for SHORT-TERM with Stoploss of 9.31 we also expect STOCK to react on Following IMPORTANT LEVELS. |
LBTSFSTOCK Price
| Open | 9.01 | Change | Price | % |
| High | 9.01 | 1 Day | -0.50 | -5.26 |
| Low | 9.01 | 1 Week | -0.50 | -5.26 |
| Close | 9.01 | 1 Month | -0.50 | -5.26 |
| Volume | 111 | 1 Year | -0.67 | -6.92 |
| 52 Week High 10.18 | 52 Week Low 8.85 | ||||
OTCGREY USA Most Active Stocks
| RTTGF | 0.02 | 0.00% |
| IARED | 24.62 | % |
| CVMCA | 22.54 | -0.75% |
| JRVMF | 0.01 | 0.00% |
| GCEA | 29.00 | -21.20% |
| AHLD | 82.75 | -2.93% |
| MAXC | 1.78 | 0.00% |
| KAKZF | 110.12 | 4.72% |
| MNSLV | 25.50 | 1.03% |
| FSEN | 2.50 | % |
OTCGREY USA Top Gainers Stocks
OTCGREY USA Top Losers Stocks
| LBTSF Daily Charts |
LBTSF Intraday Charts |
Whats New @ Bazaartrend |
LBTSF Free Analysis |
|
|
LBTSF Important Levels Intraday
| RESISTANCE | 9.01 |
| RESISTANCE | 9.01 |
| RESISTANCE | 9.01 |
| RESISTANCE | 9.01 |
| RESISTANCE | 9.01 |
| RESISTANCE | 9.01 |
| RESISTANCE | 9.01 |
| RESISTANCE | 9.01 |
LBTSF Forecast May 2025
| 4th UP Forecast | 10.61 |
| 3rd UP Forecast | 10.1 |
| 2nd UP Forecast | 9.78 |
| 1st UP Forecast | 9.46 |
| 1st DOWN Forecast | 8.56 |
| 2nd DOWN Forecast | 8.24 |
| 3rd DOWN Forecast | 7.92 |
| 4th DOWN Forecast | 7.41 |
LBTSF Weekly Forecast
| 4th UP Forecast | 9.01 |
| 3rd UP Forecast | 9.01 |
| 2nd UP Forecast | 9.01 |
| 1st UP Forecast | 9.01 |
| 1st DOWN Forecast | 9.01 |
| 2nd DOWN Forecast | 9.01 |
| 3rd DOWN Forecast | 9.01 |
| 4th DOWN Forecast | 9.01 |
LBTSF Forecast2025
| 4th UP Forecast | 11.57 |
| 3rd UP Forecast | 10.75 |
| 2nd UP Forecast | 10.24 |
| 1st UP Forecast | 9.73 |
| 1st DOWN Forecast | 8.29 |
| 2nd DOWN Forecast | 7.78 |
| 3rd DOWN Forecast | 7.27 |
| 4th DOWN Forecast | 6.45 |
Almirall S.A ( OTCGREY USA Symbol : LBTSF )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
LBTSF Business Profile
Almirall, S.A., a pharmaceutical company, engages in the research, development, manufacture, and sale of skin-health related medicines worldwide. The company offers its products for dermatological diseases comprising actinic keratosis, atopic dermatitis, cutaneous T-cell lymphoma, androgenic alopecia, psoriasis, onychomycosis, oncodermatology, acne, and orphan indications; and for the central nervous system, cardiovascular, and gastrointestinal diseases. Its products include Actikerall, Solaraze, Cordran Tape, Skilarence, Ilumetri, Seysara, Almax, Crestor, Provisacor, Sativex, Ebastel, Aczone, Tazorac, Azelex, and Veltin. Almirall, S.A. has a strategic research collaboration with Evotec AG to discover and develop first-in-class therapeutics in the field of dermatology diseases; collaborative research and license agreement with X-Chem, Inc. for the development of oral compounds for patients suffering from dermatological diseases; research collaboration with Iktos in the area of artificial intelligence for new drug design; multi-target research collaboration with the University of Dundee to develop novel targeted protein degraders medicines; and collaboration with Popit to provide a novel support solution for patients with psoriasis. It also has a strategic partnership with Tyris Therapeutics to develop gene therapies for the treatment of rare genetic dermatology diseases; and Happify Health to develop evidence-supported digital therapeutics solutions for psoriasis patients. The company was formerly known as Laboratorios Almirall, S.A. and changed its name to Almirall, S.A. in May 2009. Almirall, S.A. was founded in 1943 and is headquartered in Barcelona, Spain. Address: Ronda Del General Miter, 151, Barcelona, Spain, 08022
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service